Angiogenesis and intrauterine growth restriction

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 14, Issue 6, 2000, Pages 981-998

  Ahmed, Asif ^a   Perkins, Jonathan ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Ang 1; Angiogenesis; IUGR; PIGF; Placenta; sFlt 1; Tie 2; VEGF

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; GROWTH FACTOR RECEPTOR; NITRIC OXIDE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; AUTOCRINE EFFECT; BLOOD OXYGEN TENSION; CELL MIGRATION; CELL PROLIFERATION; FETUS CIRCULATION; GENE THERAPY; HUMAN; INTRAUTERINE GROWTH RETARDATION; MOLECULAR DYNAMICS; NONHUMAN; PLACENTA CIRCULATION; PLACENTA DEVELOPMENT; PLACENTA VILLUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; TROPHOBLAST; VASCULAR ENDOTHELIUM;

EID: 0034494140     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1053/beog.2000.0139     Document Type: Article

References (84)

1. In utero programming of chronic disease
2. Cigarette smoking as a risk factor for late fetal and early neonatal death
3. Glucose, insulin, HGH and IGF-I levels in maternal serum, amniotic fluid and umbilical venous serum: A comparison between late normal pregnancy and pregnancies complicated with diabetes and fetal growth retardation
4. Third trimester fetal growth and measures of carbohydrate and lipid metabolism in umbilical venous blood at term
5. Diagnostic value of blood sampling in fetuses with growth retardation
6. Hypoxia or hyperoxia in placental insufficiency?
7. Twins and fetal programming of blood pressure. Questioning the role of genes and maternal nutrition
8. Intrauterine growth retardation and familial short stature
9. Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies
10. Angiogenesis
11. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis
12. Angiogenesis in the early human chorion and in the primary placenta of the macaque monkey
13. The role of matrix metalloproteinase activity in the maturation of human capillary endothelial cells in vitro
14. Analysis of blood vessel; maturation processes during cyclic ovarian angiogenesis
15. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies
16. Circulatory changes in the reproductive tissues of ewes during pregnancy
17. Placental regulation of fetal growth
18. The fetal vascularisation of term human placental villi. II. Intermediate and terminal villi
19. Villous development and the pathogenesis of IUGR
20. Placental villous stroma as a model system for myofibroblast differentiation
21. Classification of human placental stem villi: Review of structural and functional aspects
22. Investigations on the vascular system of the placenta. I. General introduction and the fetal vascular system
23. The fetal vascularisation of term human placental villi. I. Peripheral stem villi
24. The development of the human placental villous tree
25. Three dimensional representation of the fetal vessel system in the placenta
26. Measurement of human fetal blood flow
27. Doppler umbilical artery waveform indices-normal values from fourteen to forty-two weeks
28. Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms
29. Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree
30. Heparin binding angiogenic growth factors in pregnancy
31. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
32. Human vascular permeability factor. Isolation from U937 cells
33. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
34. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
35. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
36. High affinity VEGF binding and developmental expression suggest Flk-I as a major regulator of vasculogenesis and angiogenesis
37. Expression of mRNA for vascular endothelial growth factor in human placenta
38. Colocalisation of vascular endothelial growth factor and its Flt-I receptor in human placenta
39. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells
40. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia
41. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
42. Failure of blood-island formation and vasculogenesis in Flk-I deficient mice
43. Role of the Flt-I receptor tyrosine kinase in regulating the assembly of vascular endothelium
44. The vascular endothelial growth factor receptor Flt-I mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
45. Role of VEGF receptor-I (Flt-I) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells
46. Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast
47. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
48. Expression of the vascular endothelial growth factor receptor, KDR, in human placenta
49. Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy
50. Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in placenta
51. Cloning and characterization of a novel human gene related to vascular endothelial growth factor
52. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
53. Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform
54. Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neutropilin-I
55. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-I and regulates plasminogen activator activity in endothelial cells
56. Localization of VEGF-B in the mouse embryo suggests a paracrine role of the growth factor in the developing vasculature
57. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia
58. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation
59. Expression of vascular endothelial growth factor and placenta growth factor in human placenta
60. Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4
61. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
62. Proteolytic processing regulates receptor specificity and activity of VEGF-C
63. Embryonic lymphagiogenesis
64. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity
65. Vascular endothelial growth factor C induces angiogenesis in vivo
66. Avian VEGF-C: Cloning, embryonic expression pattern and stimulation of the differentiation of VEGFR2-expressing endothelial cell precursors
67. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR
68. Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins
69. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids
70. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells
71. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo
72. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
73. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
74. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
75. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
76. Angiopoietin-1 and angiopoietin-2 activate trophoblast tie-2 to promote growth and migration during placental development
77. Localization of mRNA for basic fibroblast growth factor in human placenta
78. Tie-2 and angiopoietin-2 expression at the fetal-maternal interface: A receptor ligand model for vascular remodelling
79. Oxygen and placental villous development: Origins of fetal hypoxia